{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:44:26Z","timestamp":1790538266701,"version":"4.1.0"},"reference-count":21,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2016,6,21]],"date-time":"2016-06-21T00:00:00Z","timestamp":1466467200000},"content-version":"unspecified","delay-in-days":4189,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infect. Control Hosp. Epidemiol."],"published-print":{"date-parts":[[2005,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S0899823X0019734X_abs1\"><jats:title>Objectives:<\/jats:title><jats:p>To evaluate nosocomial infection (NI) surveillance strategies in French ICUs and to identify similar patterns defining subsets within which comparisons can be made.<\/jats:p><\/jats:sec><jats:sec id=\"S0899823X0019734X_abs2\"><jats:title>Design:<\/jats:title><jats:p>A questionnaire was sent to all French ICUs, and a random sample of nonresponders was interviewed.<\/jats:p><\/jats:sec><jats:sec id=\"S0899823X0019734X_abs3\"><jats:title>Participants:<\/jats:title><jats:p>Three hundred ninety-five responder ICUs (69%) in France.<\/jats:p><\/jats:sec><jats:sec id=\"S0899823X0019734X_abs4\"><jats:title>Results:<\/jats:title><jats:p>In 282 ICUs (71%), a dedicated ICU staff member was responsible for infection control activities. The microbiology laboratory was usually in the hospital (90%) and computerized (94%) but issued regular hospital microbiology records in only 48% of cases. Patients receiving mechanical ventilation, central venous catheterization, and urinary catheterization were 90%, 79%, and 60%, respectively. Patients were screened for carriage of mul-tidrug-resistant bacteria on admission and during the stay in 70% and 60% of ICUs, respectively, most often targeting MRSA. Quantitative cultures were used to diagnose ventilator-associated pneumonia (VAP) in 90% of ICUs, including distal specimens in 80% and bronchoscopy specimens in 60%. Quantitative central venous catheter (CVC)-segment cultures were used in 70% of ICUs. All CVCs were cultured routinely in 53% of the ICUs. Despite wide variations in infection control and surveillance strategies, multiple correspondence analysis identified 13 key points (4 structural variables and 9 variables concerning the diagnosis of VAP, the surveillance and diagnosis of catheter-related and urinary tract infections, and the mode of screening of MRSA carriers) that categorize the variability of French ICUs' approaches to NIs.<\/jats:p><\/jats:sec><jats:sec id=\"S0899823X0019734X_abs5\"><jats:title>Conclusion:<\/jats:title><jats:p>This study revealed profound differences in N1 surveillance strategies across ICUs, indicating a need for caution when using N1 surveillance data for comparisons and benchmarking.<\/jats:p><\/jats:sec>","DOI":"10.1086\/502482","type":"journal-article","created":{"date-parts":[[2006,4,14]],"date-time":"2006-04-14T19:58:12Z","timestamp":1145044692000},"page":"13-20","source":"Crossref","is-referenced-by-count":22,"title":["Nosocomial Infection and Multidrug-Resistant Bacteria Surveillance in Intensive Care Units: A Survey in France"],"prefix":"10.1017","volume":"26","author":[{"given":"Fran\u00e7ois","family":"L'H\u00e9riteau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Troch\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Moine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Timsit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2016,6,21]]},"reference":[{"key":"S0899823X0019734X_ref015","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199802000-00017"},{"key":"S0899823X0019734X_ref016","doi-asserted-by":"publisher","DOI":"10.1016\/S1624-0693(03)00051-3"},{"key":"S0899823X0019734X_ref013","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2807\/esm.07.09.00359-en","article-title":"The ICU-HELICS programme: towards European surveillance of hospital-acquired infections in intensive care units","volume":"7","author":"Suetens","year":"2002","journal-title":"European Surveillance"},{"key":"S0899823X0019734X_ref018","doi-asserted-by":"publisher","DOI":"10.1378\/chest.120.6.2059"},{"key":"S0899823X0019734X_ref002","volume-title":"100 Recommendations for Surveillance and Prevention of Nosocomial Infections","year":"1999"},{"key":"S0899823X0019734X_ref021","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-003-1645-y"},{"key":"S0899823X0019734X_ref014","doi-asserted-by":"publisher","DOI":"10.1016\/S1624-0693(03)00044-6"},{"key":"S0899823X0019734X_ref017","doi-asserted-by":"publisher","DOI":"10.1007\/s150100070003"},{"key":"S0899823X0019734X_ref012","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.165.7.2105078"},{"key":"S0899823X0019734X_ref008","doi-asserted-by":"publisher","DOI":"10.1177\/096228029200100106"},{"key":"S0899823X0019734X_ref004","doi-asserted-by":"publisher","DOI":"10.1016\/0196-6553(88)90053-3"},{"key":"S0899823X0019734X_ref009","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780070910"},{"key":"S0899823X0019734X_ref011","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-133-12-200012190-00021"},{"key":"S0899823X0019734X_ref007","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00134-002-1514-0","article-title":"Statement of the 4th International Consensus Conference in Critical Care on ICU-Acquired Pneumonia: Chicago, Illinois, May 2002","volume":"28","author":"Hubmayr","year":"2002","journal-title":"Intensive Care Med"},{"key":"S0899823X0019734X_ref005","doi-asserted-by":"publisher","DOI":"10.1053\/jhin.2000.0874"},{"key":"S0899823X0019734X_ref020","doi-asserted-by":"publisher","DOI":"10.1007\/BF02044110"},{"key":"S0899823X0019734X_ref010","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.21.2437"},{"key":"S0899823X0019734X_ref003","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-003-2096-1"},{"key":"S0899823X0019734X_ref001","first-page":"149","article-title":"Monitoring hospital-acquired infections to promote patient safety","volume":"49","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"S0899823X0019734X_ref019","first-page":"3","article-title":"Ventilator-associated pneumonia: caveats for benchmarking","volume":"3","author":"Eggimann","year":"2003","journal-title":"Intensive Care Med"},{"key":"S0899823X0019734X_ref006","doi-asserted-by":"publisher","DOI":"10.1086\/501893"}],"container-title":["Infection Control &amp; Hospital Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0899823X0019734X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T18:54:17Z","timestamp":1557168857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0899823X0019734X\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0899823X0019734X"],"URL":"https:\/\/doi.org\/10.1086\/502482","relation":{},"ISSN":["0899-823X","1559-6834"],"issn-type":[{"value":"0899-823X","type":"print"},{"value":"1559-6834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}